|
POLI expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62481139653892E-12 |
| Normal-vs-Stage2 |
2.26352270260577E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.693600E-01 |
| Stage1-vs-Stage3 |
6.000000E-02 |
| Stage1-vs-Stage4 |
7.342600E-03 |
| Stage2-vs-Stage3 |
2.333800E-02 |
| Stage2-vs-Stage4 |
5.739400E-03 |
| Stage3-vs-Stage4 |
2.522600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.60504984040244E-12 |
| Normal-vs-Asian |
1.62525548574877E-12 |
| Caucasian-vs-AfricanAmerican |
7.505000E-01 |
| Caucasian-vs-Asian |
5.606600E-01 |
| AfricanAmerican-vs-Asian |
9.236600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.88178419700125E-16 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
1.524190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.53499999999896E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.871000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.828400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.041600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.819800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.543600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.232000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.43840000915918E-09 |
| Classical-VS-Follicular |
2.82829999997958E-06 |
| Classical-VS-Other |
2.896800E-01 |
| Classical-VS-Normal |
3.33066907387547E-16 |
| Tall-VS-Follicular |
1.65711888655551E-12 |
| Tall-VS-Other |
2.350200E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.568400E-01 |
| Follicular-VS-Normal |
5.75373082511987E-12 |
| Other-VS-Normal |
5.760400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33226762955019E-15 |
| Normal-vs-N1 |
1.4432899320127E-15 |
| N0-vs-N1 |
3.255200E-01 |
|
|
